Abstract:Modic changes are radiographic features associated with microfracture, low-virulence organism infection and chronic inflammation with inflammatory cell infiltration in the vertebral endplate region. Mast cells, as innate immune cells similar to macrophages, are present in painful degenerated intervertebral discs. However, the involvement and mechanisms of mast cells in the development of Modic changes remain unclear. Herein, we found increased mast cell infiltration in samples from patients with Modic changes and in mouse models of Modic changes. To clarify the role of mast cells in the progression of Modic changes, we used mast cell-deficient (KITW-SH/W-SH) mice to construct a model of Modic changes and found that the severity of Modic changes in KITW-SH/W-SH mice was significantly lower than that in WT mice. These findings were further supported by the use of a mast cell-specific activator (compound 48/80) and a stabilizer (cromolyn). Furthermore, we found that mast cells were not activated via the classic IgE pathway in the Modic change models and that Mrgprb2 is the specific receptor for mast cell activation reported in recent studies. Then, we utilized Mrgprb2 knockout mice to demonstrate that Mrgprb2 knockout inhibited mast cell activation and thus reduced the degree of Modic changes. Transcriptomic sequencing revealed aberrant PI3K-AKT and MAPK pathway activation in the Mrgprb2-deficient mast cells. Additionally, Mrgpbrb2-activated mast cells regulate immune niches by recruiting macrophages, promoting M1 polarization and reducing M2 polarization, thereby promoting the progression of Modic changes. These findings suggest that mast cells may serve as a novel therapeutic target for addressing Modic changes. Degenerative disorders of the lower back are common and can greatly affect life quality. The research by Ji et al. examines the role of mast cells (a kind of immune cell) in the development of these disorders. They discovered that mast cells aid in the progression of Modic changes (a type of spinal degeneration), by affecting the metabolism of the endplates (the ends of the spinal bones) and altering the immune response. This was shown through experiments with human tissue samples, animal models, and cell studies. The results suggest that focusing on mast cells could be a potential treatment for Modic changes. The research also emphasizes the significance of the Mrgprb2 receptor (a protein that activates mast cells) as a potential drug target. "This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author."

Mrgprb2-dependent mast cell activation plays a crucial role in acute colitis

MRGPRB2/X2 and the analogous effects of its agonist and antagonist in DSS-induced colitis in mice

A mast cell specific receptor - Mrgprb2 knockout aggravates colitis by exacerbating immune system , mucosal barrier and gut microbiota disorders

Mast Cell Specific Receptor Mrgprb2 Regulating Experimental Colitis is Associated with the Microbiota-Gut-Brain Axis

Mrgprb2-mediated Mast Cell Activation Exacerbates Modic Changes by Regulating Immune Niches

Roles of a Mast Cell-Specific Receptor MRGPRX2 in Host Defense and Inflammation

Neuronal substance P-driven MRGPRX2-dependent mast cell degranulation products differentially promote vascular permeability

W1155 IL-21 Receptor Signaling Enhances NK Cell Cytolytic Activity and Induces Proinflammatory Cytokine Production in Inflammatory Bowel Disease

Typical Antimicrobials Induce Mast Cell Degranulation and Anaphylactoid Reactions Via MRGPRX2 and Its Murine Homologue MRGPRB2

Role of Nutrient-sensing Receptor GPRC6A in Regulating Colonic Group 3 Innate Lymphoid Cells and Inflamed Mucosal Healing.

Mast Cells Are Essential Intermediaries in Regulating IL-33/ST2 Signaling for an Immune Network Favorable to Mucosal Healing in Experimentally Inflamed Colons

287 Targeting the inhibitory receptor Siglec-8 on mast cells represents an attractive approach to reduce MRGPRX2-mediated mast cell activation

Ligands and Signaling of Mas-Related G Protein-Coupled Receptor-X2 in Mast Cell Activation.

Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth

Inhibition of mast cell degranulation by novel small molecule MRGPRX2 antagonists

A Connective Tissue Mast-Cell-Specific Receptor Detects Bacterial Quorum-Sensing Molecules and Mediates Antibacterial Immunity.

MrgprX2 regulates mast cell degranulation through PI3K/AKT and PLCγ signaling in pseudo-allergic reactions

Transcriptional modulation of pattern recognition receptors in acute colitis in mice

Mast cells mediate early neutrophil recruitment and exhibit anti-inflammatory properties via the formyl peptide receptor 2/lipoxin A4 receptor

P028 A pathogenic role of activated mucosal-associated invariant T cells in an animal model of Inflammatory Bowel Disease

P086 Identification of a Novel Immunometabolic Target and Agonist for PLXDC2 for Amelioration of DSS Colitis Model in Mice